Cowealth Medical Holding Co Ltd (4745) - Total Liabilities

Latest as of December 2025: NT$1.99 Billion TWD ≈ $62.55 Million USD

Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has total liabilities worth NT$1.99 Billion TWD (≈ $62.55 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 4745 net assets growth trend to track the company's year-over-year net asset growth rate.

Cowealth Medical Holding Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Cowealth Medical Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Cowealth Medical Holding Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Cowealth Medical Holding Co Ltd Competitors by Total Liabilities

The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Aasen Sparebank
OL:AASB
Norway Nkr6.22 Billion
Proximar Seafood AS
OL:PROXI
Norway Nkr1.07 Billion
Argent Minerals Ltd
AU:ARD
Australia AU$463.67K
GEE Group Inc
NYSE MKT:JOB
USA $8.97 Million
HAMILTON GLB.OPP.LS-0001
F:5DS
Germany €5.46 Million
Milae Bioresources Co. Ltd
KQ:218150
Korea ₩17.71 Billion
Eupe Corporation Bhd
KLSE:6815
Malaysia RM374.69 Million
Haiwan International Development Co Ltd
TWO:3252
Taiwan NT$1.90 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Cowealth Medical Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cowealth Medical Holding Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.79 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cowealth Medical Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cowealth Medical Holding Co Ltd (2017–2025)

The table below shows the annual total liabilities of Cowealth Medical Holding Co Ltd from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 NT$1.99 Billion
≈ $62.55 Million
+12.54%
2024-12-31 NT$1.76 Billion
≈ $55.58 Million
+9.78%
2023-12-31 NT$1.61 Billion
≈ $50.63 Million
-19.85%
2022-12-31 NT$2.00 Billion
≈ $63.16 Million
+6.89%
2021-12-31 NT$1.88 Billion
≈ $59.09 Million
-3.73%
2020-12-31 NT$1.95 Billion
≈ $61.38 Million
-5.80%
2019-12-31 NT$2.07 Billion
≈ $65.16 Million
-6.08%
2018-12-31 NT$2.20 Billion
≈ $69.38 Million
+12.00%
2017-12-31 NT$1.97 Billion
≈ $61.95 Million
--

About Cowealth Medical Holding Co Ltd

TWO:4745 Taiwan Medical Devices
Market Cap
$25.27 Million
NT$802.00 Million TWD
Market Cap Rank
#24289 Global
#1519 in Taiwan
Share Price
NT$10.90
Change (1 day)
+4.81%
52-Week Range
NT$10.40 - NT$26.85
All Time High
NT$42.03
About

Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more